Evidence map›Paper›PMID 29854833›Full record

ArticleJournal of immunology research2018

Downregulation of iNOS, IL-1

Yanli Hao, Hao Niu, Shuhong An, Ming Wang, Zhaojin Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanli HaoInstitute of Basic Medical Science, Taishan Medical University, Taian, China.
Hao NiuInstitute of Basic Medical Science, Taishan Medical University, Taian, China.
Shuhong AnInstitute of Basic Medical Science, Taishan Medical University, Taian, China.ORCID 0000-0003-1881-9084
Ming WangDepartment of Human Anatomy, Taishan Medical University, Taian, China.
Zhaojin WangInstitute of Basic Medical Science, Taishan Medical University, Taian, China.ORCID 0000-0001-9152-5280
Taishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protease-activated receptor 4 (PAR4) is implicated in the inhibition of visceral hyperalgesia. In the present study, the effects of PAR4 activation on visceral hypersensitivity and expression of inflammatory mediators, including interleukin-1

Indexed as

AnimalsAnimals, NewbornAnti-Inflammatory AgentsCells, CulturedColonDisease Models, AnimalDown-RegulationHumansHyperalgesiaInterleukin-1betaMAP Kinase Signaling SystemMast CellsNitric Oxide Synthase Type IIOligopeptidesRatsReceptors, Purinergic P2X7alanyl-tyrosyl-prolyl-glycyl-lysyl-phenylalanineAnti-Inflammatory AgentsInterleukin-1betaNitric Oxide Synthase Type IIOligopeptidesprotease-activated receptor 4Receptors, Purinergic P2X7Receptors, ThrombinTryptases

Identifiers

PMID29854833
PMCPMC5966670
OpenAlexW2800960707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.